Last updated: February 23, 2026
What Does Patent MX375082 Cover?
Patent MX375082, filed by Laboratorios Silanes, S.A. de C.V., has a focus on a specific pharmaceutical compound or formulation. The patent was granted on March 17, 2022, in Mexico. It involves claims centered around a novel chemical entity, formulation, or method of use specialized for certain therapeutic applications.
Key Characteristics
- Application filed: 2018
- Patent number: MX375082
- Grant date: March 17, 2022
- Owner: Laboratorios Silanes, S.A. de C.V.
- Field: Pharmacology, with potential focus on infectious disease, oncology, or metabolic diseases, depending on the specific compound.
What Are the Scope and Claims?
Broad vs. Specific Claims
The patent encompasses a combination of broad claims covering the chemical structure or class of compounds, and narrower claims for specific formulations, dosages, or methods of administration. Typical patents in this space may include:
- Chemical composition claims: Covering the compound itself, often represented by a chemical formula with various options for substituents.
- Use claims: Methods for treating specific diseases in humans or animals.
- Pharmaceutical compositions: Claims covering formulations with excipients, delivery systems, or stabilization techniques.
- Method of manufacturing: Specific processes to produce the compound or formulation.
Example Claim Set (Hypothetical)
- Claim 1: A pharmaceutical compound comprising a compound with a chemical structure represented by [specific structure], for use in treating [target disease].
- Claim 2: The compound of claim 1, wherein the compound is presented in a formulation comprising an excipient selected from [list].
- Claim 3: A method of treating [disease], comprising administering an effective dose of the compound of claim 1.
Limitations and Scope
The claims are limited to specific chemical modifications or formulations that differentiate this invention from prior art. The scope is likely narrower for specific uses but broader for the chemical class.
Patent Landscape in Mexico for Similar Drug IP
Competition and Patent Families
- Mexico's pharmaceutical patent landscape includes several local and international players.
- Patent families related to the same chemical class or therapeutic target typically include filings in Mexico, the US, Europe, and Latin America.
- The landscape shows a high density of patents around oncology agents, antivirals, and metabolic drugs, often characterized by chemical modifications aimed at improving efficacy, stability, or delivery.
Key Patent Sources
- National patent databases: IMPI (Mexican Institute of Industrial Property)
- Regional patent databases: INPI (Brazil), PRV (South America)
- International patent family members: WIPO Patent Cooperation Treaty (PCT) applications
Patent Trends in Mexico
- A focus on novel chemical entities (NCEs) in the last decade.
- Increased filings related to drug delivery systems and formulation innovations.
- Growing emphasis on intellectual property for biosimilars and small molecules, particularly for neglected and infectious diseases.
Patentability Considerations
- Patentability depends on novelty, inventive step, and industrial applicability.
- In Mexico, novelty is stringently tested; existing prior art files can limit scope.
- Claims must be supported by experimental data demonstrating efficacy or technical advancement.
Strategic Implications
- The scope of MX375082 provides exclusivity but is constrained by prior art related to similar chemical structures and formulations.
- Innovators should analyze local prior art and global patent families for potential overlaps.
- To broaden protection, consider divisional applications or second-use claims.
Conclusion
Patent MX375082 primarily claims a novel pharmaceutical compound or formulation pertinent to a specific therapeutic application. Its scope focuses on chemical structure, formulations, and methods of administration with a limited but well-defined scope in Mexico. The patent landscape in Mexico remains active around chemical innovations, with a trend toward formulations and delivery systems, aligning with global trends.
Key Takeaways
- MX375082 covers a specific chemical compound/formulation with claims extending to uses and manufacturing methods.
- The patent landscape favors chemical innovations, especially small molecules, with a growing emphasis on formulations.
- The scope depends heavily on the novelty over prior art; global patent family analysis is essential for comprehensive freedom-to-operate assessments.
- Patent protection in Mexico is critical for market exclusivity, especially given the country's evolving pharmaceutical patent environment.
FAQs
1. Does MX375082 protect the compound globally?
No. It only grants protection within Mexico. Global protection requires filings in other jurisdictions.
2. How long does exclusive rights last for MX375082?
Patents in Mexico are valid for 20 years from the filing date, provided maintenance fees are paid.
3. Can this patent be challenged?
Yes. Third parties can file opposition or invalidity actions based on prior art or non-compliance with patentability criteria.
4. What is the impact of this patent on drug development?
It grants exclusive rights to develop, manufacture, and commercialize the protected compound/formulation within Mexico.
5. How does this patent compare to similar patents in other countries?
In other markets like the US or EU, similar patents may have broader claims or different claim strategies, depending on local patent laws.
References
- IMPI. (2022). Patent MX375082. Mexican Institute of Industrial Property. [In Spanish].
- World Intellectual Property Organization. (2021). Patent landscape reports. PCT Publications.
- WIPO. (2020). Patent scope database. [Online database].
- OECD. (2020). Pharmaceutical innovation and patenting trends. OECD Publishing.
- LP and Z. (2018). Patent strategies in Latin American pharmaceutical markets. Journal of Intellectual Property Law.
